Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc. (CELZ) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
celz · stock forecast · 1 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Buy
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $2.17
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $2.12 | ↓ 2.09% |
1-day model range: $2.1–$2.15. Peak: $2.15 (-2.09%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · CELZ · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2022-02-25 | Roth Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Creative Medical Technology Holdings, Inc. (CELZ) stock. Of the recent 1 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover CELZ.
Analyst Recommendation Trends
CELZ analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$23M
↓ 61.0% YoY
Revenue Next Year
$34M
↑ 44.5% YoY
EPS This Year
$-1.57
EPS Next Year
$-1.51
↓ 3.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast CELZ EPS of $-1.57 for the current fiscal year, based on estimates from 1 analysts. The CELZ revenue forecast is $23M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CELZ stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CELZ price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The CELZ short-term stock prediction for tomorrow is $2.12 (-2.09%).
Creative Medical Technology Holdings, Inc. trades on NASDAQ under the ticker CELZ. The CELZ stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
CELZ forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month CELZ price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $2.17.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.